RecruitingPhase 1 / Phase 2NCT07012031
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Sponsor: National Cancer Institute (NCI)
Tampa, FL · +6 more sites